OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Psychiatry is in need of tools to improve personalised treatment given the high rates of adverse drug reactions and generally low remission rates. Here, I discuss how pharmaco-genetics approaches have elucidated that some treatment outcomes in severe psychiatric disorders are associated with polygenic risk profiles. I also give examples of real-world epidemiological approches that have potential to curtail risks of psychotropic mediation use and improve response rates. Finally, I summarise some of the insights Mendelian Randomisation studies conducted at my lab have provided. Overall, the aim of the talk is to critically appraise the hypothesis that more personalised prescribing is possible in psychiatry. I look forward to critical thoughts, suggestions, lively discussions, and possible future collaborations.
zoom.us/j/98643323773?pwd=bL0TW4vweAlQzIlL5VEFHKYiEaVYPl.1
Meeting ID: 986 4332 3773
Passcode: 758174
